MCID: MCR191
MIFTS: 47

Microscopic Colitis malady

Category: Gastrointestinal diseases

Aliases & Classifications for Microscopic Colitis

About this section

Aliases & Descriptions for Microscopic Colitis:

Name: Microscopic Colitis 11 13
 
Colitis, Microscopic 38 67

Classifications:



External Ids:

Disease Ontology11 DOID:0060182
MeSH38 D046728
SNOMED-CT61 235753003
NCIt44 C38504

Summaries for Microscopic Colitis

About this section
Wikipedia:70 Microscopic colitis refers to two related medical conditions which cause diarrhea: collagenous colitis... more...

MalaCards based summary: Microscopic Colitis, also known as colitis, microscopic, is related to pyoderma gangrenosum and lymphocytic colitis. An important gene associated with Microscopic Colitis is CD79A (CD79a Molecule), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and SIDS Susceptibility Pathways. Affiliated tissues include colon, t cells and thyroid, and related mouse phenotypes are neoplasm and renal/urinary system.

Disease Ontology:11 A colitis that can only be diagnosed by the examination of colon tissue under a microscope.

Related Diseases for Microscopic Colitis

About this section

Diseases related to Microscopic Colitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 326)
idRelated DiseaseScoreTop Affiliating Genes
1pyoderma gangrenosum28.8IL2, IL6, SLC6A4, TNF
2lymphocytic colitis28.2CD79A, HLA-DQB1, HLA-DRB1, IFNG, IL4, IL6
3collagenous colitis11.8
4colitis10.7
5common variable immunodeficiency10.6HLA-DRB1, TNF
6weber syndrome10.6HLA-DRB1, TNF
7rhizomelic pseudopolyarthritis10.6HLA-DRB1, TNF
8fruit allergy10.6HLA-DQB1, HLA-DRB1
9wolffian duct adenocarcinoma10.6HLA-DQB1, HLA-DRB1
10quinquaud's decalvans folliculitis10.6HLA-DQB1, HLA-DRB1
11pediatric systemic lupus erythematosus10.5HLA-DQB1, HLA-DRB1
12spondylarthropathy10.5HLA-DQB1, HLA-DRB1
13ileocolitis10.5CD79A, TNF
14mitochondrial encephalomyopathy10.5HLA-DQB1, HLA-DRB1
15panuveitis10.5HLA-DRB1, TNF
16spastic paraplegia-paget disease of bone syndrome10.5HLA-DRB1, TNF
17ovarian papillary cystadenoma10.5HLA-DQB1, HLA-DRB1
18nebulin-related early-onset distal myopathy10.5HLA-DQB1, HLA-DRB1
19linitis plastica10.5IL2, TNF
20potato nose10.5HLA-DRB1, TNF
21suppurative uveitis10.5CD79A, TNF
22fallopian tube disease10.5CD79A, IL2
23transvestism10.5SLC6A4, TNF
24perforation of bile duct10.5HLA-DQB1, TNF
25autoinflammation, lipodystrophy, and dermatosis syndrome10.4HLA-DQB1, HLA-DRB1
26keratomalacia10.4HLA-DQB1, TNF
27kaposi sarcoma10.4HLA-DRB1, IL6
28foster-kennedy syndrome10.4HLA-DQB1, HLA-DRB1
296q terminal deletion syndrome10.4IL4, TNF
30thrombocytopenia due to platelet alloimmunization10.4HLA-DQB1, HLA-DRB1
31arachnoiditis10.4HLA-DRB1, TNF
32monoclonal paraproteinemia10.4CD79A, IL6
33aortic arch interruption10.4IL6, TNF
34basidiobolomycosis10.4IL4, TNF
35cutaneous leishmaniasis10.4IL6, TNF
36paralytic lagophthalmos10.4IL4, TNF
37aniseikonia10.4CD79A, IL4
38granular cell tumor10.4CD79A, IL4
39malignant histiocytic disease10.4CD79A, IL2
40hemometra10.4IL6, TNF
41tricho odonto onycho dermal syndrome10.4IL6, TNF
42scrotum paget's disease10.4IL6, TNF
43hypoparathyroidism, x-linked10.4CD79A, IL4
44conventional leiomyosarcoma10.4HLA-DRB1, IL6
45antigen-peptide-transporter 2 deficiency10.4IL6, TNF
46hypothyroidism10.4IL6, TNF
47ethmoid sinus adenoid cystic carcinoma10.4IL6, TNF
48neurotic excoriation10.4IL4, TNF
49autoimmune polyendocrine syndrome10.4IL6, TNF
50cyclothymic disorder10.4CD79A, IL6

Graphical network of the top 20 diseases related to Microscopic Colitis:



Diseases related to microscopic colitis

Symptoms for Microscopic Colitis

About this section

Drugs & Therapeutics for Microscopic Colitis

About this section

Drugs for Microscopic Colitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
InfliximabapprovedPhase 4378170277-31-3
Synonyms:
 
Ig gamma-1 chain C region
Remicade
2Antirheumatic AgentsPhase 4, Phase 2, Phase 310627
3Dermatologic AgentsPhase 45674
4Gastrointestinal AgentsPhase 48109
5
BudesonideapprovedPhase 3, Phase 242251333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide MMX
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
Horacort
 
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
6
Inulinapproved, nutraceuticalPhase 2, Phase 31029005-80-524763
Synonyms:
(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethy
189444-25-5
887747-94-6
AC1L2NNM
AI3-19506
CID24763
DB00638
 
EINECS 232-684-3
INULIN
Inulin USP 27
Inulin [BAN]
Inulin and sodium chloride
Inulin from Jerusalem artichokes
LS-186416
LS-187349
7Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 212767
8Peripheral Nervous System AgentsPhase 3, Phase 222776
9Respiratory System AgentsPhase 3, Phase 24818
10HormonesPhase 3, Phase 213979
11Anti-Asthmatic AgentsPhase 3, Phase 23369
12Hormone AntagonistsPhase 3, Phase 212778
13Bronchodilator AgentsPhase 3, Phase 22856
14Anti-Inflammatory AgentsPhase 3, Phase 210355
15glucocorticoidsPhase 3, Phase 24920
16Autonomic AgentsPhase 3, Phase 29774
17MesalaminePhase 2, Phase 316089-57-6
18Analgesics, Non-NarcoticPhase 2, Phase 36260
19AnalgesicsPhase 2, Phase 311287
20Anti-Inflammatory Agents, Non-SteroidalPhase 2, Phase 34295
21
LevanPhase 2, Phase 3179013-95-022833608
Synonyms:
(2,6-beta-D-Fructosyl)N
(2,6-beta-D-Fructosyl)N+1
(2,6-beta-delta-Fructosyl)N
 
(2,6-beta-delta-Fructosyl)N+1
2,6-beta-D-Fructan
2,6-beta-delta-Fructan
Fructan
Levan N
22ColaNutraceuticalPhase 2, Phase 31881
23ChicoryNutraceuticalPhase 2, Phase 37
24
Glatiramer Acetateapproved, investigationalPhase 293147245-92-93081884
Synonyms:
(2S)-2,6-diaminohexanoic acid
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid
(2S)-2-aminopentanedioic acid
(2S)-2-aminopropanoic acid
147245-92-9
AC1MIXQC
Aventis brand of copolymer 1
C089995
CID3081884
COP-1
Copaxone
Copolymer 1
 
Copolymer-1
Copoylmer 1
Glatiramer acetate
Glatiramer acetate [USAN]
L-Glutamic acid peptide with L-alanine, L-lysine and L-tyrosine, acetate (salt)
L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt)
LS-186971
LS-71889
TV 5010
TV-5010
TV5010
Teva brand of copolymer 1
UNII-5M691HL4BO
acetic acid
25Immunosuppressive AgentsPhase 212770
26Adjuvants, ImmunologicPhase 22484
27
Adalimumabapproved478331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
28
Methylene blueinvestigational8161-73-4
Synonyms:
Basic Blue 9
C.I. basic blue 9
Lowacryl blue 9
Methylene blue
Methylene blue anhydrous
Methylthioninium chloride
 
Urolene Blue
aniline violet
methylenium ceruleum
methylthionine chloride
methylthioninium chloride
methylthioninium chloride Proveblue
tetrametylthionine chloride
29Tolonium Chloride9
30Pharmaceutical Solutions7793
31
Bismuth1297440-69-916682734, 105143
Synonyms:
17034_FLUKA
24267-48-9
25243-76-9
264008_ALDRICH
265462_ALDRICH
265470_ALDRICH
452386_ALDRICH
556130_ALDRICH
7440-69-9
83Bi
95372_ALDRICH
95372_FLUKA
95375_FLUKA
AC1NSDYX
AC1O4PN8
AR-1I0647
BISMUTH, 99.95%
 
BISMUTH, 99.999%
Bi
Bismut
Bismuth standard for AAS
Bismuth standard for ICP
Bismuth(III) nitrate solution
Bismuth, elemental
Bismuth-209
C15471
CHEBI:33301
CID5359367
EINECS 231-177-4
HSDB 2078
LS-44708
LTBB002773
MolPort-003-925-759
Wismut
bismuth
bismuto
32Anti-Ulcer Agents1767
33Antacids1767

Interventional clinical trials:

(show all 27)
idNameStatusNCT IDPhase
1Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative ColitisCompletedNCT01408810Phase 4
2Long-Term Treatment of Collagenous Colitis With BudesonideUnknown statusNCT00139165Phase 3
3Trial of Mesalamine for the Treatment of Active Microscopic ColitisCompletedNCT00952952Phase 2, Phase 3
4Budesonide Treatment for Lymphocytic ColitisCompletedNCT00180050Phase 3
5Budesonide for Maintenance Treatment of Collagenous ColitisCompletedNCT00180076Phase 3
6Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous ColitisCompletedNCT00450086Phase 3
7SOIBD Collagenous Colitis Maintenance StudyCompletedNCT01278082Phase 3
8Budesonide for Induction of Remission in Incomplete Microscopic ColitisRecruitingNCT02142634Phase 3
9Budesonide Versus Mesalazine Versus Placebo in Lymphocytic ColitisRecruitingNCT01209208Phase 3
10Ulcerative Colitis Relapse Prevention by PrebioticsNot yet recruitingNCT02865707Phase 2, Phase 3
11Budesonide Versus Placebo for the Treatment of Lymphocytic ColitisTerminatedNCT00217022Phase 2, Phase 3
12A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's DiseaseUnknown statusNCT00731172Phase 2
13Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)Unknown statusNCT01787253
14Changes in Stem Cells of the Colon in Response to Increased Risk of Colorectal CancerUnknown statusNCT01075893
15Case-Control Study to Identify Risk Factors for Microscopic ColitisCompletedNCT01928667
16Ussing Experiments to Evaluate the Role of Medication-induced Microscopic ColitisCompletedNCT02303132
17Confocal Laser Endomicroscopy Findings in Patients With Proctosigmoiditis Before and After Initiation of TreatmentCompletedNCT01684514
18Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD)CompletedNCT01289366
19Risk Factors for Microscopic ColitisRecruitingNCT02699333
20Usefulness of Chromoendoscopy in Diagnosing Microscopic ColitisRecruitingNCT01504048
21Early Detection of Tumors of the Digestive Tract by Confocal EndomicroscopyRecruitingNCT02284802
22Fecal Microbiota Transplantation for C Diff InfectionRecruitingNCT01905709
23Confocal Laser Endomicroscopy for Assessment of Mucosal Healing in Ulcerative ColitisRecruitingNCT02676817
24Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)RecruitingNCT02049775
25OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the AgesRecruitingNCT02523118
26The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel DiseaseRecruitingNCT02481687
27Treatment of Microscopic ColitisTerminatedNCT00184171

Search NIH Clinical Center for Microscopic Colitis


Cochrane evidence based reviews: colitis, microscopic

Genetic Tests for Microscopic Colitis

About this section

Anatomical Context for Microscopic Colitis

About this section

MalaCards organs/tissues related to Microscopic Colitis:

35
Colon, T cells, Thyroid, Bone, Small intestine

Animal Models for Microscopic Colitis or affiliated genes

About this section

MGI Mouse Phenotypes related to Microscopic Colitis:

40 (show all 12)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.7CD79A, IFNG, IL2, IL6, TNF
2MP:00053678.3CD79A, HLA-DQB1, IFNG, IL4, IL6
3MP:00053888.1HLA-DQB1, IFNG, IL2, IL4, IL6, TNF
4MP:00053898.0HLA-DQB1, IFNG, IL2, IL4, IL6, TNF
5MP:00053708.0HLA-DQB1, IFNG, IL2, IL4, IL6, TNF
6MP:00053817.9HLA-DQB1, IFNG, IL2, IL4, IL6, TNF
7MP:00053797.7HLA-DQB1, IFNG, IL2, IL4, IL6, SLC6A4
8MP:00053767.2CD79A, HLA-DQB1, IFNG, IL2, IL4, IL6
9MP:00053876.9CD79A, HLA-DQB1, IFNG, IL2, IL4, IL6
10MP:00053976.8CD79A, HLA-DQB1, IFNG, IL2, IL4, IL6

Publications for Microscopic Colitis

About this section

Articles related to Microscopic Colitis:

(show top 50)    (show all 305)
idTitleAuthorsYear
1
Diagnosis and Management of Microscopic Colitis. (27897155)
2017
2
Interaction of Ethnicity and H. pylori Infection in the Occurrence of Microscopic Colitis. (28070826)
2017
3
Microscopic colitis: A literature review. (28001266)
2016
4
Distinguishing Microscopic Colitis From Irritable Bowel Syndrome. (26707680)
2016
5
Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders. (26913568)
2016
6
Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")? (27895976)
2016
7
The association between the intake of specific dietary components and lifestyle factors and microscopic colitis. (27460269)
2016
8
Microscopic colitis that is not so microscopic. (25922142)
2015
9
P080. Persistence and sensitivity of colonic biopsies for microscopic colitis in a regional cohort. (25717537)
2015
10
Microscopic colitis (lymphocytic and collagenous), eosinophilic colitis, and celiac disease. (26034409)
2015
11
Microscopic colitis. (25925924)
2015
12
Is microscopic colitis really microscopic? (25720998)
2015
13
Ethnic Distribution of Microscopic Colitis in the United States. (26226142)
2015
14
Drug exposure and risk of microscopic colitis: a nationwide Danish case-control study with 5751 cases. (25153503)
2014
15
Microscopic Colitis - Clinical and Pathologic Perspectives. (24407107)
2014
16
Smoking- and alcohol habits in relation to the clinical picture of women with microscopic colitis compared to controls. (24456904)
2014
17
Differential expression of miR-31 between inflammatory bowel disease and microscopic colitis. (25665881)
2014
18
Microscopic Colitis: A Review. (25039699)
2014
19
Letter: Persisting clinical symptoms in microscopic colitis in remission--authors' reply. (24903433)
2014
20
Evolution of Microscopic Colitis to Giant Cell Colitis Without Significant Intraepithelial Lymphocytosis or Thickened Collagen Plate. (25006169)
2014
21
Microscopic colitis and colorectal neoplastic lesion rate in chronic nonbloody diarrhea: a prospective, multicenter study. (24681653)
2014
22
The Epidemiology of Microscopic Colitis in Olmsted County From 2002 to 2010: A Population-Based Study. (24120840)
2013
23
Efficacy of anti-TNF therapies in refractory severe microscopic colitis. (22115383)
2011
24
Cytokine gene polymorphism in microscopic colitis association with the IL-6-174 GG genotype. (21527852)
2011
25
Low bone mass in microscopic colitis. (21595910)
2011
26
Review article: Microscopic colitis--lymphocytic, collagenous and 'mast cell' colitis. (21545473)
2011
27
Usefulness of colonoscopic examination with indigo carmine in diagnosing microscopic colitis. (22057822)
2011
28
Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study. (21039674)
2010
29
Patients with drug-induced microscopic colitis should not be included in controlled trials assessing the efficacy of anti-inflammatory drugs in microscopic colitis. (19717133)
2009
30
Microscopic colitis: a review for the surgical endoscopist. (19865548)
2009
31
Microscopic colitis and endoscopy. (19841492)
2009
32
Microscopic colitis: a common and an easily overlooked cause of chronic diarrhoea. (18395161)
2008
33
Microscopic colitis with giant cells: a clinico-pathological review of 11 cases and comparison with microscopic colitis without giant cells. (18985521)
2008
34
The risk of microscopic colitis in solid-organ transplantation patients: a population-based study. (18192911)
2008
35
Clozapine-induced microscopic colitis: a case report and review of the literature. (18004122)
2007
36
The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. (17135309)
2007
37
Spectrum of microscopic colitis in a tertiary care centre in India. (18384001)
2007
38
Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. (16775121)
2007
39
A higher diagnostic profile is possible for microscopic colitis. (16886923)
2006
40
Microscopic colitis in routine colonoscopies. (16534662)
2006
41
Review article: drug-induced microscopic colitis - proposal for a scoring system and review of the literature. (16097993)
2005
42
Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. (14960513)
2004
43
Microscopic colitis. (15703617)
2004
44
Lansoprazole-associated microscopic colitis: a case series. (12425567)
2002
45
Postcholecystectomy microscopic colitis: is bile acid malabsorption a triggering factor? (11374729)
2001
46
Microscopic colitis--no longer an appropriate term? (9576441)
1998
47
Microscopic colitis syndrome. (7615277)
1995
48
Association of lymphocytic (microscopic) colitis with tropical sprue. (8155860)
1994
49
Response to treatment of microscopic colitis. (7919463)
1994
50
Is microscopic colitis due to bile-salt malabsorption? (3691268)
1987

Variations for Microscopic Colitis

About this section

Expression for genes affiliated with Microscopic Colitis

About this section
Search GEO for disease gene expression data for Microscopic Colitis.

Pathways for genes affiliated with Microscopic Colitis

About this section

Pathways related to Microscopic Colitis according to GeneCards Suite gene sharing:

(show all 46)
idSuper pathwaysScoreTop Affiliating Genes
19.4IL4, IL6
29.3IL6, SLC6A4, TNF
39.1IL4, IL6, TNF
4
Show member pathways
9.1IFNG, IL2, TNF
5
Show member pathways
9.1IFNG, IL2, TNF
69.0HLA-DRB1, IFNG, IL2
79.0IFNG, IL6, TNF
89.0IFNG, IL6, TNF
99.0IFNG, IL6, TNF
10
Show member pathways
9.0IFNG, IL6, TNF
119.0IFNG, IL6, TNF
129.0IFNG, IL6, TNF
138.9IFNG, IL2, IL4
148.9IFNG, IL2, IL4
158.9IFNG, IL2, IL4
168.9IFNG, IL2, IL6
17
Show member pathways
8.8IFNG, IL4, IL6
188.7HLA-DRB1, IL4, IL6, TNF
198.7IL2, IL4, IL6, TNF
208.6IFNG, IL2, IL4, TNF
21
Show member pathways
8.6IFNG, IL2, IL4, TNF
22
Show member pathways
8.6IFNG, IL2, IL4, TNF
238.6IFNG, IL2, IL6, TNF
24
Show member pathways
8.6IFNG, IL2, IL6, TNF
258.6IFNG, IL2, IL6, TNF
26
Show member pathways
8.6IFNG, IL2, IL6, TNF
27
Show member pathways
8.6IFNG, IL2, IL6, TNF
28
Show member pathways
8.5HLA-DRB1, IFNG, IL2, IL4
29
Show member pathways
8.5IFNG, IL4, IL6, TNF
308.4HLA-DQB1, HLA-DRB1, IL2, IL6, TNF
318.4IFNG, IL2, IL4, IL6
32
Show member pathways
8.4IFNG, IL2, IL4, IL6
338.3CD79A, IFNG, IL2, IL4, TNF
34
Show member pathways
8.2HLA-DQB1, HLA-DRB1, IFNG, IL4, TNF
358.2HLA-DQB1, HLA-DRB1, IFNG, IL6, TNF
368.2HLA-DQB1, HLA-DRB1, IFNG, IL6, TNF
37
Show member pathways
8.0IFNG, IL2, IL4, IL6, TNF
388.0IFNG, IL2, IL4, IL6, TNF
397.7CD79A, IFNG, IL2, IL4, IL6, TNF
40
Show member pathways
7.7CD79A, IFNG, IL2, IL4, IL6, TNF
417.7HLA-DRB1, IFNG, IL2, IL4, IL6, TNF
42
Show member pathways
7.5CD79A, HLA-DQB1, HLA-DRB1, IFNG, IL2, IL4
43
Show member pathways
7.5CD79A, HLA-DQB1, HLA-DRB1, IFNG, IL2, IL4
44
Show member pathways
7.5CD79A, HLA-DQB1, HLA-DRB1, IFNG, IL2, IL6
45
Show member pathways
7.2HLA-DQB1, HLA-DRB1, IFNG, IL2, IL4, IL6
46
Show member pathways
7.2HLA-DQB1, HLA-DRB1, IFNG, IL2, IL4, IL6

GO Terms for genes affiliated with Microscopic Colitis

About this section

Cellular components related to Microscopic Colitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:004261310.0HLA-DQB1, HLA-DRB1
2external side of plasma membraneGO:00098978.2CD79A, IFNG, IL4, IL6, TNF

Biological processes related to Microscopic Colitis according to GeneCards Suite gene sharing:

(show all 34)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of mononuclear cell migrationGO:007167710.3IL4, TNF
2positive regulation of chemokine productionGO:003272210.3IL6, TNF
3epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.3IL6, TNF
4positive regulation of vitamin D biosynthetic processGO:006055710.2IFNG, TNF
5positive regulation of calcidiol 1-monooxygenase activityGO:006055910.2IFNG, TNF
6positive regulation of membrane protein ectodomain proteolysisGO:005104410.2IFNG, TNF
7negative regulation of lipid storageGO:001088810.2IL6, TNF
8positive regulation of immunoglobulin secretionGO:005102410.2IL2, IL6
9positive regulation of activated T cell proliferationGO:004210410.1IL2, IL4
10positive regulation of B cell activationGO:005087110.1IL4, IL6
11positive regulation of osteoclast differentiationGO:004567210.1IFNG, TNF
12neutrophil apoptotic processGO:000178110.1IFNG, IL6
13positive regulation of tyrosine phosphorylation of Stat5 proteinGO:004252310.1IL2, IL4
14B cell activationGO:004211310.0CD79A, IL4
15positive regulation of T cell differentiationGO:004558210.0IL2, IL4
16negative regulation of growth of symbiont in hostGO:004413010.0IFNG, TNF
17positive regulation of MHC class II biosynthetic processGO:00453489.9IFNG, IL4
18positive regulation of chemokine biosynthetic processGO:00450809.7IFNG, IL4, TNF
19interferon-gamma-mediated signaling pathwayGO:00603339.7HLA-DQB1, HLA-DRB1, IFNG
20positive regulation of protein phosphorylationGO:00019349.7IL2, IL4, TNF
21humoral immune responseGO:00069599.6IFNG, IL6, TNF
22adaptive immune responseGO:00022509.6CD79A, IFNG, IL2
23positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.5IL4, IL6, TNF
24T cell receptor signaling pathwayGO:00508529.5HLA-DQB1, HLA-DRB1, IFNG
25cellular response to lipopolysaccharideGO:00712229.5IFNG, IL6, TNF
26positive regulation of isotype switching to IgG isotypesGO:00483049.5IFNG, IL2, IL4
27defense response to protozoanGO:00428329.4IFNG, IL4, IL6
28positive regulation of nitric oxide biosynthetic processGO:00454299.3IFNG, IL6, TNF
29positive regulation of gene expressionGO:00106288.8IFNG, IL6, SLC6A4, TNF
30positive regulation of T cell proliferationGO:00421028.7IFNG, IL2, IL4, IL6
31immune responseGO:00069558.6HLA-DQB1, IL2, IL4, MR1
32response to drugGO:00424938.4IFNG, IL4, IL6, SLC6A4
33positive regulation of cell proliferationGO:00082848.1IFNG, IL2, IL4, IL6
34positive regulation of transcription from RNA polymerase II promoterGO:00459448.0IFNG, IL2, IL4, IL6, TNF

Molecular functions related to Microscopic Colitis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1peptide antigen bindingGO:00426058.9HLA-DQB1, HLA-DRB1, MR1
2growth factor activityGO:00080838.7IL2, IL4, IL6
3cytokine activityGO:00051257.9IFNG, IL2, IL4, IL6, TNF

Sources for Microscopic Colitis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet